Novartis drug Afinitor gets EU nod for breast cancer
 |
| A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel |
ZURICH (Reuters) - Novartis drug Afinitor, expected to become a major seller for the Swiss drugmaker, was approved by European regulators to treat women with a certain type of breast cancer, the company said on Monday. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. American health regulators also backed the drug as a breast cancer treatment. ... read more..
source:http://yhoo.it/Q4CbCI
No comments:
Post a Comment